Kay Stremler
Keine laufenden Positionen mehr
Profil
Kay Stremler worked as a Director of International Quality Operations at Immunex Corp.
and as a Director of Clinical Supply & Pharmaceutical Sciences at Esperion Therapeutics, Inc. She also worked as a Vice President of Manufacturing at Theriva Biologics, Inc. and as a Vice President of Quality & Supply Chain Management at AlphaCore Pharma LLC.
Stremler received her undergraduate and doctorate degrees from the University of Utah.
Ehemalige bekannte Positionen von Kay Stremler
Unternehmen | Position | Ende |
---|---|---|
AlphaCore Pharma LLC
AlphaCore Pharma LLC Miscellaneous Commercial ServicesCommercial Services AlphaCore Pharma LLC engages in pharmaceutical research. It develops recombinant human lecithin-cholesterol acyltransferase enzyme that helps reducing cholesterol from the body. The company was founded by Reyn Homan, Bruce J. Auerbach, and Brian R. Krausen on June 20, 2007 and is headquartered in Ann Arbor, MI. | Corporate Officer/Principal | - |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Corporate Officer/Principal | - |
ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | - |
THERIVA BIOLOGICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Kay Stremler
University of Utah | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
THERIVA BIOLOGICS, INC. | Health Technology |
ESPERION THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
AlphaCore Pharma LLC
AlphaCore Pharma LLC Miscellaneous Commercial ServicesCommercial Services AlphaCore Pharma LLC engages in pharmaceutical research. It develops recombinant human lecithin-cholesterol acyltransferase enzyme that helps reducing cholesterol from the body. The company was founded by Reyn Homan, Bruce J. Auerbach, and Brian R. Krausen on June 20, 2007 and is headquartered in Ann Arbor, MI. | Commercial Services |